(150 days)
No
The document describes a mechanical surgical instrument and does not mention any software, algorithms, or data processing that would indicate the use of AI/ML.
No
The device is described as providing temporary stabilization for bone fractures, malunions, and nonunions, and is fabricated from titanium. This indicates it is an orthopedic implant for structural support rather than a device that provides therapy for a disease or condition.
No
The device is a system for stabilizing tibial fractures, including nails and instruments for insertion and targeting. It is used for treatment, not diagnosis. The performance studies and intended use descriptions focus on mechanical properties and structural support, not diagnostic capabilities.
No
The device description explicitly states it includes physical components like tibial nails fabricated from titanium and a modified targeter device and its components. The performance studies also focus on physical testing of these components (stiffness, bending load, torque, impulse, drop, cadaveric testing).
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for "temporary stabilization of various types of fractures, malunion and nonunion of the tibia." This is a surgical intervention, not a diagnostic test performed on samples from the human body.
- Device Description: The device is described as a "Tibial Nailing System" including nails, screws, and a targeter device. These are physical implants and surgical instruments.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting specific analytes, or providing diagnostic information about a patient's health status based on in vitro testing.
The device is a surgical implant and associated instrumentation used for orthopedic procedures.
N/A
Intended Use / Indications for Use
The T2 Tibial Nailing System is intended to provide temporary stabilization of various types of fractures, malunion, and nonunion of the tibia. The nails are inserted using an opened or closed technique and can be statically, dynamically, and compression locked.
The T2 Tibial Nailing System is indicated for long bone fracture fixation, specifically tibial fracture fixation, which may include the following:
- o Open and closed tibial fractures
- · Pseudoarthodosis and correction osteotomy
- Pathologic fractures, impending pathologic fractures, and tumor resections .
- Nonunion and malunion .
Product codes
HSB
Device Description
This Traditional 510(k) submission is being supplied to the US FDA to include a modified targeter device and its components as Class II accessories as part of the Suprapatellar Instrument (SPI) System included in the T2 Tibial Nailing System, previously cleared under K003018 as the Titan Tibial Nail. The T2 Tibial Nailing System was determined substantially equivalent via 510/k) K003018 and included tibial nails and associated accessories such as locking screws. compression screws and end caps. There are three nail designs for the T2 Tibial Nail: Proximal. Standard, and Distal. These T2 tibial nails are fabricated from titanium and are available sterile. The T2 tibia targeter devices are intended to be used as part of the T2 Tibial Nailing System. In addition, this submission addresses a modification made to some components of the targeting device.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Tibia
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Non-clinical laboratory testing was performed on the targeting device and its components to determine substantial equivalence. Testing demonstrated that the subject targeter device is substantially equivalent to the predicate device currently cleared for marketing. The following testing was performed:
- Stiffness Testing .
- Bending Load o
- o Transferable Torque of Connections
- . Trunsferable Torque between Nail and Nail Adapter
- 0 Impulse Test
- . Drop Test
- o Cadaveric Testing
Clinical testing was not required for this submission.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3020 Intramedullary fixation rod.
(a)
Identification. An intramedullary fixation rod is a device intended to be implanted that consists of a rod made of alloys such as cobalt-chromium-molybdenum and stainless steel. It is inserted into the medullary (bone marrow) canal of long bones for the fixation of fractures.(b)
Classification. Class II.
0
510(k) Summarv
T2 Tibial Nailing Svstem Proprietary Name: Intramedullary Fixation Rod Common Name: Rod. Fixation. Intramedullary and Accessory 21 CFR Classification Name and Reference: $888.3020 Proposed Regulatory Class: Class II OCT 1 0 2013 Product Codes: H&B For Information Contact: Estela Celi, RAC Regulatory Affairs Specialist Stryker Trauma AG 325 Corporate Drive Mahwah. NJ 07430 Phone: (201) 831-6461; Fax (201) 831-3461 Legally Marketed Devices to Which K003018 - Titan Tibial Nail K111667 - Synthes Suprapatellar Insertion Substantial Equivalence Is Claimed: Instruments Date Prepared: August 30, 2013
Description
This Traditional 510(k) submission is being supplied to the US FDA to include a modified targeter device and its components as Class II accessories as part of the Suprapatellar Instrument (SPI) System included in the T2 Tibial Nailing System, previously cleared under K003018 as the Titan Tibial Nail. The T2 Tibial Nailing System was determined substantially equivalent via 510/k) K003018 and included tibial nails and associated accessories such as locking screws. compression screws and end caps. There are three nail designs for the T2 Tibial Nail: Proximal. Standard, and Distal. These T2 tibial nails are fabricated from titanium and are available sterile. The T2 tibia targeter devices are intended to be used as part of the T2 Tibial Nailing System. In addition, this submission addresses a modification made to some components of the targeting device.
Intended Use
The T2 Tibial Nailing System is intended to provide temporary stabilization of various types of fractures, malunion, and nonunion of the tibia. The nails are inserted using an opened or closed technique and can be statically, dynamically, and compression locked.
1
Indications
The T2 Tibial Nailing System is intended to provide temporary stabilization of various types of fractures, malunion and nonunion of the tibia. The nails are inserted using an opened or closed technique and can be statically, dynamically and compressed locked.
The T2 Tibial Nailing System is indicated for long bone fracture fixation. specifically tibial fracture fixation, which may include the following:
- o Open and closed tibial fractures
- · Pseudoarthodosis and correction osteotomy
- Pathologic fractures, impending pathologic fractures, and tumor resections .
- Nonunion and malunion .
Summary of Technologies
The subject device is substantially equivalent in intended use, materials and performance characteristics to the predicate devices. Inclusion of the targeter device and its components as accessories to the T2 Tibial Nailing System does not alter the device technology.
Non-Clinical Testing
Non-clinical laboratory testing was performed on the targeting device and its components to determine substantial equivalence. Testing demonstrated that the subject targeter device is substantially equivalent to the predicate device currently cleared for marketing. The following testing was performed:
- Stiffness Testing .
- Bending Load o
- o Transferable Torque of Connections
- . Trunsferable Torque between Nail and Nail Adapter
- 0 Impulse Test
- . Drop Test
- o Cadaveric Testing
Clinical Testing
Clinical testing was not required for this submission.
Conclusion
The T2 Tibial Nailing System and its components are substantially equivalent to the predicate devices identified in this premarket notification.
2
Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized symbol resembling an eagle or bird in flight, composed of three curved lines. The symbol is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G60 Silver Spring, MD 20993-0002
October 10, 2013
Stryker Trauma AG Ms. Estela Celi Regulatory Affairs Specialist 325 Corporate Drive Mahwah, New Jersey 07430
Re: K131365
Trade/Device Name: T2 Tibial Nailing System Regulation Number: 21 CFR 888.3020 Regulation Name: Intramedullary fixation rod Regulatory Class: Class II Product Code: HSB Dated: September 13, 2013 Received: September 13, 2013
Dear Ms. Celi:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
3
Page 2 - Ms. Estela Celi
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (30!) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincercly yours,
Erin | Keith
for
Mark Melkerson
- Director
- Division of Orthopedic Devices Office of Device Evaluation Center for Devices and
- Radiological Health
Enclosure
4
Indications for Use
KI31365 510(k) Number (if known):
Device Name: T2 Tibial Nailing System
Indications for Use:
The T2 Tibial Nailing System is intended to provide temporary stabilization of various types of fractures, malunion and nonunion of the tibia. The nails are inserted using an opened or closed technique and can be statically, dynamically and compressed locked.
The T2 Tibial Nailing System is indicated for long bone fracture fixation, specifically tibial fracture fixation, which may include the following:
- Open and closed tibial fractures .
- Pseudoarthodosis and correction osteotomy .
- Pathologic fractures, impending pathologic fractures, and tumor resections �
- Nonunion and malunion .
Over-The-Counter Use Prescription Use X AND/OR (21 CFR 807 Subpart C) (Part 21 CFR 801 Subpart D) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Casey L. Hanley, Rh.D.
Division of Orthopedic Devices